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ABSTRACT
Studies have indicated that approximately 30% of people with heart disease experience
major depressive disorder (MDD). Despite strong clinical evidence of a link between the two
diseases, the neurobiological processes involved in the relationship are poorly understood. A
growing number of studies are revealing similar neuroanatomical and neurochemical
abnormalities resulting from both depression and heart disease. The locus coeruleus (LC) is a
group of neurons in the pons that synthesize and release norepinephrine, and that is known to
play a significant role in depression pathobiology. For example, there is evidence that tyrosine
hydroxylase (TH) is elevated in the LC in depression. In addition, there is evidence that the LC
plays a role in cardiovascular autonomic regulation. The hippocampus is another region that
exhibits abnormalities in both depression and heart disease. In this study, the levels of TH in the
hippocampus and LC were examined in the guinea pig pressure-overload model of heart disease.
TH levels were also measured in the pressure-overload model treated with vagal nerve
stimulation, a new investigational therapeutic intervention in heart disease. This study found that
there were no changes in TH levels in the LC or the hippocampus of the pressure-overload model
or in the pressure-overload model treated with vagal nerve stimulation.
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1. INTRODUCTION
Cardiovascular disease (CVD) and major depressive disorder (MDD) are two of the most
prominent diseases in our healthcare system today. CVD is the leading cause of death in the
United States, killing an estimated 610,000 people annually (CDC, NCHS, 2015). The National
Institute of Health reports that 6.7% of Americans suffer from depression (Kessler et al., 2005).
While the two diseases can appear as separate entities, they are known to be clinically linked.
Approximately 30% of people with heart disease develop symptoms of depression (Lesperance
and Frasure-Smith, 2000). Also, people with depression are more likely to develop CVD (Hare,
Toukhsati, Johansson, and Jaarsma, 2014). Unfortunately, depressed patients with heart disease
typically experience more adverse events, such as an increase in symptoms, poorer responses to
medication, a slower rehabilitation, and ultimately a poorer quality of life. Depression also
increases the probability of additional cardiac complications, as well as increases the mortality
rate (Nair, Farmer, Gongora, and Dehmer, 2012; Parissis et al., 2007). There is also evidence of a
correlational relationship, with the mortality rate and number of cardiac complications increasing
with the severity of the depression (Hare et al., 2014). Despite the many associations between the
two diseases, the underlying biological relationship is very poorly understood.
The locus coeruleus (LC), a group of neurons located in the pons, is an area of interest in
the neurobiological link between CVD and MDD. It is the primary source of the
neurotransmitter norepinephrine in the brain and plays a role in many physiological responses,
including numerous behaviors. Tyrosine hydroxylase (TH), an enzyme found in the LC, is the
rate-limiting enzyme in the biosynthesis of norepinephrine. Studies have shown the relevancy of
the LC in the pathophysiology of depression. The expression level of TH in the LC in brain
tissue from depressed humans was shown to be significantly higher than that of age-matched
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sudden-death control cases (Ordway, Smith, and Haycock, 1994; Zhu, Klimek, Dilley, Haycock,
Stockmeier, Overholser, Meltzer, and Ordway, 1999). Research has also found that the LC plays
a role in central control of the cardiovascular system by being connected to many cardiovascular
regulatory centers. For example, nitrergic stimulation in the LC was shown to modulate heart
rate and blood pressure (Yao, Finkelstein, and Lawrence, 1999).
The hippocampus, known to play a vital role in learning and memory, is an additional
brain area known to present pathology in depression, while likewise being impacted
pathologically by heart disease. In regards to CVD, research has shown that the release of
proinflammatory cytokines that occurs in CVD deleteriously affects the limbic system,
particularly of the hippocampus (Liu et al., 2013). Apoptosis has been shown to occur in the
hippocampus following experimentally-induced myocardial infarction in rats (Wann et al., 2007;
Kaloustian et al. 2008). In the pathology of depression, atrophy in the hippocampus is associated
with MDD, with recurrent depression being associated with a greater loss of hippocampal
volume (Sapolsky, 2001).
Another interesting similarity between CVD and MDD involves a treatment known as
vagal nerve stimulation (VNS). VNS is administered through a pulse generating device that is
surgically implanted into the chest and connected to the left vagus nerve. Initially used for
epilepsy, VNS is now approved for use in patients with treatment-resistant depression. Research
has shown marked improvement in patients with treatment-resistant MDD treated with VNS,
despite the mechanism not being fully understood (Schlaepfer et al., 2008). More recently, VNS
has gained great interest as a potential treatment to alleviate cardiac pathology following a
myocardial infarction. VNS was shown to significantly increase the long-term survival after
chronic heart failure in a rat model (Li et al, 2004). More recently, VNS was evaluated in
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patients with chronic heart failure, and showed some promising results (Premchand, 2014).
While many of the underlying mechanisms of VNS are unknown, its role as a potentially
effective treatment in both MDD and CVD make it a point of interest.

2. METHODS
2.1 Pressure-Overload and Vagal Nerve Stimulation
Guinea pigs were utilized in this study (n=18). The guinea pigs were randomly assigned
to one of three treatment groups: 1) sham control group (CO), 2) pressure-overload group (PO),
and 3) pressure-overload in combination with vagal nerve stimulation group (PO + VNS). The
pressure-overload in the PO and PO + VNS group was produced by a 15-20% chronic aortic
constriction. For the PO + VNS group, a vagal nerve stimulation device was implanted in the
guinea pigs two weeks prior to the surgery to produce pressure-overload. The device was
attached to the right cervical vagus nerve and delivered stimulation (20 Hz, 0.1 mA) in a
continuous cycle of 14 seconds on and 48 seconds off. The guinea pigs were maintained for 60
days post-PO. The PO + VNS group received stimulation during the 60 days. The sham controls
were also maintained for the same length of time. The animals were then terminated, and the
target brain tissues were dissected and stored at 80°C. This protocol was approved by East
Tennessee State University’s IACUC.
2.2 Collection of Locus Coeruleus and Hippocampal Tissue
Tissue from the LC was collected from the brainstem, using a micro-punch (2-mm
diameter). Hippocampal tissue was collected from a 50 um thick section of the temporal lobe,
using a micro-punch (3.5-mm diameter). The collected tissue was stored at 80°C.
2.3 Measuring Tyrosine Hydroxylase Immunoreactivity
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Protein from the micropunched LC and hippocampal tissue was isolated, solubilized, and
separated by 4-10% polyacrylamide gel electrophoresis. The separated proteins were transferred
to PVDF membranes and treated with polyclonal primary antibody generated against rabbit TH.
The membrane was then exposed to horseradish peroxidase linked secondary antibody. The THimmunoreactivity (ir) was then quantified and normalized to actin-ir by chemiluminescence
using a G-box imaging system.
2.4 Statistical Analysis
TH-ir levels were analyzed for each group (CO, PO, PO+VNS) for the LC and
hippocampal tissue. Statistical analysis was completed using a one-way analysis of variance
(ANOVA) with a p-value set at 0.05 to determine statistical significance.
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3. RESULTS
3.1 Locus Coeruleus
The LC is the primary site for the synthesis of norepinephrine in the brain. This synthesis
is dependent upon the levels of TH; the rate-limiting enzyme. Levels of TH in the LC tissue were
measured to determine whether there were any changes induced in the PO group or in the PO
group receiving VNS. No significant changes were found between the TH levels of the sham
controls and the PO group. In addition, TH levels from the PO group that received VNS did not
exhibit a significant difference from the sham controls or from the PO group. These results are
expressed in Figure 1.

Locus Coeruleus

Treatment Group
Figure 1: Measurement of Tyrosine Hydroxylase Immunoreactivity in the LC. TH-ir
normalized by actin-ir was examined in control (CO; open circles), pressureoverload (PO; closed circles), and pressure-overload with VNS (PO+VNS; closed
triangles) groups in micropunched tissue samples collected from the LC and
hippocampus.
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3.2 Hippocampus
Noradrenergic neurons of the LC project to the hippocampus where they synthesize and
release norepinephrine. Levels of TH-ir were measured in hippocampal tissue from the three
groups of animals to determine whether any changes were induced by PO or by PO plus VNS.
No significant changes in TH-ir levels were observed between the sham controls and the PO
group. In addition, no significant changes in the levels of TH-ir were observed in the PO group
that also received vagal nerve stimulation. These results are expressed in Figure 2.

Hippocampus

Treatment Group
Figure 1: Measurement of Tyrosine Hydroxylase Immunoreactivity in the
Hippocampus. TH-ir normalized by actin-ir was examined in control (CO; open
circles), pressure-overload (PO; closed circles), and pressure-overload with VNS
(PO+VNS; closed triangles) groups in micropunched tissue samples collected
from the LC and hippocampus.
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4. DISCUSSION
The results from this study suggest that the PO guinea pig model does not significantly
impact LC or hippocampal biochemistry at the level of the enzyme TH. Additionally, the results
from the PO model combined with VNS imply that this treatment does not significantly
influence the levels of TH in the LC or hippocampus. Despite a lack of significant differences in
TH-ir, a positive trend was observed between the controls and the PO model. A positive trend
was also observed between the controls and the PO model receiving VNS. Due to the small
sample size, it is possible that a significant difference went undetected. By increasing the sample
size, it would have allowed for a better statistical analysis between the groups. It is noteworthy
that elevation in the activity of the LC is typically paralleled by an increase in the expression of
TH protein, since increased activity translates to increased norepinephrine release requiring
greater synthetic capacity for norepinephrine (Zhu, Klimek, Dilley, Haycock, Stockmeier,
Overholser, Meltzer, and Ordway, 1999). Therefore, the present findings suggest that the PO
model used did not significantly increase the activity of the LC. Likewise, at least in PO animals,
VNS did not appear to change the activity of the LC.
This study indicated that the PO produced no effect on TH-ir. However, the lack of
significant effects may have resulted from the modesty of the PO model with respect to the
severity of heart failure. It has been shown that damage to the hippocampus occurs in rats during
myocardial infarctions (Kaloustian et al. 2008). In this study, the PO was created by a 15-20%
chronic aortic constriction. A higher amount of chronic aortic constriction, simulating a more
severe condition, may have influenced brain pathology.
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People with CVD have an increased probability of developing MDD. Depression
significantly increases the morbidity and mortality in individuals with CVD, making continued
research in this area a significant need.
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